Form 4: Privia Health Director Receives Equity Grant

Director Francis S. Soistman Jr. was granted 8,463 restricted stock units in Privia Health Group, Inc.

Summary

• Director Francis S. Soistman Jr. acquired 8,463 restricted stock units (RSUs) on May 20, 2026.
• The grant was issued under the Issuer's 2021 Omnibus Incentive Plan.
• The RSUs are scheduled to vest on the earlier of the day before the 2027 annual meeting or the first anniversary of the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Standard market risks associated with equity ownership and potential dilution from incentive plans.

Future Outlook

The RSUs are expected to vest by May 2027 or the 2027 annual meeting of stockholders.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice to ensure long-term alignment with shareholder value in the healthcare services sector.

Comparison to Industry Standards

• The grant of restricted stock units to directors is consistent with standard compensation practices for publicly traded healthcare companies.
• The vesting schedule aligns with typical one-year director equity retention cycles.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders; represents standard director incentive structure.

Next Steps

• Vesting of restricted stock units in 2027.

Key Dates

Keywords

Privia Health, PRVA, Form 4, Insider Trading, Equity Compensation, Director